Ethnic Disparities and Trends in Glycemic Control Among Adults With Type 2 Diabetes in the U.S. From 1988 to 2002

Fan, Tao; Koro, Carol E.; Fedder, Donald O.; Bowlin, Steven J.

doi:10.2337/dc05-2238

Cited by 46 publications

(26 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This meta-analysis combined 11 studies to evaluate the overall mean difference. For the studies that were excluded but that reported A1C above target thresholds (i.e., Ͼ7%), glycemic control was worse among Hispanics than among non-Hispanic whites (27)(28)(29)(30)(31)(32). The strengths of this analysis are its inclusion of a variety of study designs, the ability to examine A1C differences by study type, data collection methods, and care type, and the use of previously unpublished data (15,17,18).…”

Section: Discussionmentioning

confidence: 99%

Disparities in A1C Levels Between Hispanic and Non-Hispanic White Adults With Diabetes

et al. 2008

View full text Add to dashboard Cite

OBJECTIVE -Hispanics have higher rates of diabetes and diabetes-related complications than do non-Hispanic whites. A meta-analysis was conducted to estimate the difference between the mean values of A1C for these two groups.RESEARCH DESIGN AND METHODS -We executed a PubMed search of articles published from 1993 through July 2007. Data sources included PubMed, Web of Science, Cumulative Index to Nursing and Allied Health, the Cochrane Library, Combined Health Information Database, and Education Resources Information Center. Data on sample size, age, sex, A1C, geographical location, and study design were extracted. Cross-sectional data and baseline data from clinical trials and cohort studies for Hispanics and non-Hispanic whites with diabetes were included. Studies were excluded if they included individuals Ͻ18 years of age or patients with pre-diabetes or gestational diabetes.RESULTS -A total of 495 studies were reviewed, of which 73 contained data on A1C for Hispanics and non-Hispanic whites, and 11 met the inclusion criteria. Meta-analysis revealed a statistically significant mean difference (P Ͻ 0.0001) of Ϫ0.46 (95% CI Ϫ0.63 to Ϫ0.33), correlating to an ϳ0.5% higher A1C for Hispanics. Grouping studies by design (cross-sectional or cohort), method of data collection for A1C (chart review or blood sampling), and care type (managed or nonmanaged) yielded similar results.CONCLUSIONS -In this meta-analysis, A1C was ϳ0.5% higher in Hispanic patients with diabetes than in non-Hispanic patients. Understanding the reasons for this disparity should be a focus for future research. Diabetes Care 31:240-246, 2008

show abstract

Section: Discussionmentioning

confidence: 99%

Disparities in A1C Levels Between Hispanic and Non-Hispanic White Adults With Diabetes

et al. 2008

View full text Add to dashboard Cite

show abstract

“…A recent meta-analysis comparing glycemic control between non-Hispanic whites and African Americans revealed an A1C difference of approximately 0.65% in favor of the former [17]. A separate review of the data from National Health and Nutrition Examination Survey (NHANES) III to NHANES 2001NHANES -2002 showed that Mexican-Americans have statistically poorer glycemic control compared with non-Hispanic whites, while for non-Hispanic blacks there was a trend, not statistically significant, for poorer control compared with non-Hispanic whites [18]. While in non-Hispanic whites the level of glycemic control improved between the two surveys [2], no such improvement in A1C values over time was seen for the minority populations.…”

mentioning

confidence: 89%

Ethnic disparities in diabetes care: myth or reality?

Meneghini

2008

Current Opinion in Endocrinology, Diabetes &Amp; Obesity

View full text Add to dashboard Cite

show abstract

“…In order to achieve HbA1c targets (<7.0%), patients must reach desirable fasting (90 mg/dL -130 mg/dL) and postprandial glucose levels (<180 mg/dL) (American Diabetes Association, 2006). However, two thirds of patients with T2DM remain unable to reach the HbA1c targets (Koro, 1988;Fan, 2006). Blood glucose levels are dependent on the dynamic processes of hepatic production of glucose and skeletal muscle use of glucose.…”

Section: Introductionmentioning

confidence: 99%

Role of Incretin, Incretin Analogues and Dipeptidyl Peptidase 4 Inhibitors in the Pathogenesis and Treatment of Diabetes Mellitus

Papazafiropoulou¹,

Kardara²,

Pappas³

2011

Diabetes - Damages and Treatments

View full text Add to dashboard Cite

Ethnic Disparities and Trends in Glycemic Control Among Adults With Type 2 Diabetes in the U.S. From 1988 to 2002

Cited by 46 publications

References 6 publications

Disparities in A1C Levels Between Hispanic and Non-Hispanic White Adults With Diabetes

Disparities in A1C Levels Between Hispanic and Non-Hispanic White Adults With Diabetes

Ethnic disparities in diabetes care: myth or reality?

Role of Incretin, Incretin Analogues and Dipeptidyl Peptidase 4 Inhibitors in the Pathogenesis and Treatment of Diabetes Mellitus

Contact Info

Product

Resources

About